Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria

James A. McQuillan, Andrew J. Mitchell, Yuen Fern Ho, Valéry Combes, Helen J. Ball, Jacob Golenser, Georges E. Grau, Nicholas H. Hunt*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

Cerebral malaria (CM) is a fatal complication of Plasmodium falciparum infection. Using a well defined murine model, we observed the effect on disease outcome of temporarily reducing parasite burden by anti-malarial drug treatment. The anti-malarial treatment regime chosen decreased parasitaemia but did not cure the mice, allowing recrudescence of parasites. These mice were protected against CM, despite their parasitaemia having increased, following treatment cessation, to levels surpassing that associated with CM in mice not treated with the drug. The protection was associated with reduced levels of cytokines, chemokines, CD8+ T cells and parasites in the brain. The results suggest that the development of the immunopathological response that causes CM depends on a continuous stimulus provided by parasitised red blood cells, either circulating or sequestered in small vessels.

Original languageEnglish
Pages (from-to)155-163
Number of pages9
JournalInternational Journal for Parasitology
Volume41
Issue number2
DOIs
StatePublished - Feb 2011

Keywords

  • Anti-malarial drug
  • CD8+ T cells
  • Cerebral malaria
  • Mouse model
  • Plasmodium berghei

Fingerprint

Dive into the research topics of 'Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria'. Together they form a unique fingerprint.

Cite this